Literature DB >> 10964119

Difficulties in diagnosing and treating depression in the terminally ill cancer patient.

M Lloyd-Williams1.   

Abstract

It is estimated that for a quarter of all patients with advanced metastatic cancer, depression will be significant symptom. However up to 80% of the psychological and psychiatric morbidity which develops in cancer patients goes unrecognised and untreated. One of the main difficulties in establishing a diagnosis of an illness where there are no biological markers, physical signs, or diagnostics tests is deciding what can be called "appropriate sadness" as patients approach the end of life and what is a depressive illness. Criteria for diagnosing depression are discussed together with reasons why established screening tools used in other populations may not be appropriate to screen for depression in terminally ill patients. The use of antidepressants and the role of cognitive therapies are also discussed. For effective treatment of a depressive illness, treatment with antidepressant medication needs to be initiated sooner rather than later and patients may need close supervision to ensure compliance. The awareness of depression, the identification of symptoms, and the initiation of treatment is essential if patients are to be offered optimum palliation of psychological as well as physical symptoms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964119      PMCID: PMC1741750          DOI: 10.1136/pmj.76.899.555

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  21 in total

1.  Anhedonia: exclusion from the pleasure dome.

Authors:  P Snaith
Journal:  BMJ       Date:  1992-07-18

2.  Helping cancer patients disclose their concerns.

Authors:  P Maguire; A Faulkner; K Booth; C Elliott; V Hillier
Journal:  Eur J Cancer       Date:  1996-01       Impact factor: 9.162

3.  Maladaptive coping and affective disorders among cancer patients.

Authors:  M Parle; B Jones; P Maguire
Journal:  Psychol Med       Date:  1996-07       Impact factor: 7.723

Review 4.  The assessment and prevalence of affective disorders in advanced cancer.

Authors:  M E Lynch
Journal:  J Palliat Care       Date:  1995       Impact factor: 2.250

Review 5.  Depression undertreatment: lost cohorts, lost opportunities?

Authors:  T S Brugha
Journal:  Psychol Med       Date:  1995-01       Impact factor: 7.723

6.  Dextroamphetamine treatment for depression in terminally ill patients.

Authors:  M M Burns; S J Eisendrath
Journal:  Psychosomatics       Date:  1994 Jan-Feb       Impact factor: 2.386

7.  Improving the detection of psychiatric problems in cancer patients.

Authors:  P Maguire
Journal:  Soc Sci Med       Date:  1985       Impact factor: 4.634

Review 8.  Cancer and depression.

Authors:  D Spiegel
Journal:  Br J Psychiatry Suppl       Date:  1996-06

9.  Treatment of depression in cancer patients.

Authors:  P Maguire; P Hopwood; N Tarrier; T Howell
Journal:  Acta Psychiatr Scand Suppl       Date:  1985

10.  Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

Authors:  T Ibbotson; P Maguire; P Selby; T Priestman; L Wallace
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  10 in total

1.  Depression in older patients with advanced colorectal cancer is closely connected with immunosuppressive acidic protein.

Authors:  Rong Li; Jie Yang; Jihua Yang; Weijun Fu; Hua Jiang; Juan Du; Chunyang Zhang; Hao Xi; Jian Hou
Journal:  Metab Brain Dis       Date:  2013-08-22       Impact factor: 3.584

2.  Assessment of depression and anxiety in adult cancer outpatients: a cross-sectional study.

Authors:  Nauman A Jadoon; Waqar Munir; Mohammad A Shahzad; Zeshan S Choudhry
Journal:  BMC Cancer       Date:  2010-10-29       Impact factor: 4.430

3.  The Beck Depression Inventory (BDI-II) and a single screening question as screening tools for depressive disorder in Dutch advanced cancer patients.

Authors:  Franca Warmenhoven; Eric van Rijswijk; Yvonne Engels; Cornelis Kan; Judith Prins; Chris van Weel; Kris Vissers
Journal:  Support Care Cancer       Date:  2011-01-18       Impact factor: 3.603

4.  Anxiety and depression in patients with head and neck cancer: 6-month follow-up study.

Authors:  Yi-Shan Wu; Pao-Yen Lin; Chih-Yen Chien; Fu-Min Fang; Nien-Mu Chiu; Chi-Fa Hung; Yu Lee; Mian-Yoon Chong
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-27       Impact factor: 2.570

5.  Core Symptoms of Major Depressive Disorder among Palliative Care Patients.

Authors:  Ng Su Huey; Ng Chong Guan; Jesjeet Singh Gill; Koh Ong Hui; Ahmad Hatim Sulaiman; Sharmilla Kunagasundram
Journal:  Int J Environ Res Public Health       Date:  2018-08-16       Impact factor: 3.390

Review 6.  End-of-life issues in the acute and critically ill patient.

Authors:  Eric A Savory; Catherine A Marco
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2009-04-22       Impact factor: 2.953

Review 7.  The effectiveness of treatment for depression/depressive symptoms in adults with cancer: a systematic review.

Authors:  S Williams; J Dale
Journal:  Br J Cancer       Date:  2006-02-13       Impact factor: 7.640

Review 8.  The prevalence of depression and anxiety among Chinese adults with cancer: a systematic review and meta-analysis.

Authors:  Yi-Long Yang; Li Liu; Yang Wang; Hui Wu; Xiao-Shi Yang; Jia-Na Wang; Lie Wang
Journal:  BMC Cancer       Date:  2013-08-22       Impact factor: 4.430

9.  Prevalence of Depression and Anxiety amongst Cancer Patients in a Hospital Setting: A Cross-Sectional Study.

Authors:  Anish Khalil; Muhammad Faheem; Ammad Fahim; Haran Innocent; Zainab Mansoor; Shehrbano Rizvi; Hizra Farrukh
Journal:  Psychiatry J       Date:  2016-09-26

10.  Risk of depressive symptoms before and after the first hospitalisation for cancer: Evidence from a 16-year cohort study in the Czech Republic.

Authors:  Wentian Lu; Hynek Pikhart; Anne Peasey; Ruzena Kubinova; Alexandra Pitman; Martin Bobak
Journal:  J Affect Disord       Date:  2020-07-15       Impact factor: 4.839

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.